Selectis Health (GBCS) Receivables - Net (2013 - 2026)

Selectis Health has reported Receivables - Net for 12 years, with the latest figure at $2.3 million in Q4 2025.

• Quarterly Receivables - Net fell 12.98% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (down 12.98% YoY) and the FY2025 annual result came in at $2.3 million, down 12.98% from the prior year.
• Receivables - Net fell to $2.3 million in Q4 2025 per GBCS's latest filing, from $3.2 million in the prior quarter.
• Over five years, Receivables - Net peaked at $4.4 million in Q3 2021 and troughed at -$469302.0 in Q2 2022.
• A 5-year average of $2.6 million and a median of $2.7 million in 2023 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net plunged 114.51% in 2022, then jumped 648.79% in 2023.
• Over 5 years, Receivables - Net stood at $3.5 million in 2021, then declined by 17.17% to $2.9 million in 2022, then fell by 28.0% to $2.1 million in 2023, then increased by 25.12% to $2.6 million in 2024, then fell by 12.98% to $2.3 million in 2025.
• According to Business Quant data, Receivables - Net over the past three periods registered $2.3 million, $3.2 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.